Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (178)

2024

  1. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

  2. Prioritization of initiatives 2024–2027 of the strategic map of pharmaceutical outpatient care of the Spanish Society of Hospital Pharmacy

    Farmacia Hospitalaria

2023

  1. Antifungal Combination Eye Drops for Fungal Keratitis Treatment

    Pharmaceutics, Vol. 15, Núm. 1

  2. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

  3. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

    Epilepsy and Behavior, Vol. 145

2022

  1. A Review of Population Pharmacokinetic Analyses of Linezolid

    Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817

  2. Adherencia terapéutica de ácido obeticólico: experiencia real utilizando sistemas de monitorización de medicación electrónicos

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 4, pp. 260-264

  3. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  4. Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial

    European Respiratory Journal, Vol. 60, Núm. 2

  5. Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial

    Nutrients, Vol. 14, Núm. 1

  6. Evidencia seleccionada y cherry picking en formulación magistral

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 2, pp. 100-101

  7. Impact of Enhanced Phagocytosis of Glycated Erythrocytes on Human Endothelial Cell Functions

    Cells, Vol. 11, Núm. 14

  8. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  9. Microbiome in Immune-Mediated Uveitis

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  10. Minimal invasive fluorescence methods to quantify advanced glycation end products (AGEs) in skin and plasma of humans

    Methods, Vol. 203, pp. 103-107

  11. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery

    Pharmaceutics, Vol. 14, Núm. 4

  12. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

  13. Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  14. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

    Scientific Reports, Vol. 12, Núm. 1

  15. Response to inhaled ceftazidime in patients with non-cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa

    Clinical Respiratory Journal, Vol. 16, Núm. 11, pp. 768-773